Register entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 6
- Exclusivities
- 1
- Countries
- 0
Exclusivity
Patents and exclusivities
6| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 11291728 | PEDMARKsodium thiosulfate | product | Jul 2039 |
| 11510984 | PEDMARKsodium thiosulfate | product | Jul 2039 |
| 11617793 | PEDMARKsodium thiosulfate | product | Jul 2039 |
| 11964018 | PEDMARKsodium thiosulfate | use | Jul 2039 |
| 11992530 | PEDMARKsodium thiosulfate | use | Jul 2039 |
| 11998604 | PEDMARKsodium thiosulfate | use | Jul 2039 |
| Product | Exclusivity | Until |
|---|---|---|
| PEDMARKSODIUM THIOSULFATE | ODE-384 Orphan drug | Sept 2029 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| PEDMARK | SODIUM THIOSULFATE | injection, solution, intravenous | 73077-010NDA |
Compare
Other companies listing sodium thiosulfate
- Hunan Jiudian Pharmaceutical Co.,Ltd.0 sites · 15 NDC
- Medi-Physics, Inc. dba GE Healthcare0 sites · 10 NDC
Enquiry
Common questions
- Is Fennec Pharmaceuticals Inc. FDA approved?
- Fennec Pharmaceuticals Inc. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Fennec Pharmaceuticals Inc. make?
- 1 product is listed under Fennec Pharmaceuticals Inc. in the openFDA NDC Directory, most often as injection, solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.